| Company Needs to Raise Substantial Capital to Continue Operations EMERYVILLE, Calif., March 30, 2012 /PRNewswire/ -- Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced financial results for the year ended December 31, 2011. (Logo: http://photos.prnewswire.com/prnh/20111110/SF04662LOGO) "In 2011 we initiated our Phase 3 trial for Menerba for the treatment of menopausa...continued BNVI menopause pharmaceutical clinical |
Friday, March 30, 2012
Bionovo Announces 2011 Highlights and Year-End Financial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment